Last reviewed · How we verify

Magnesium sulfate in erector spinae plane block

Assiut University · Phase 1 active Small molecule Quality 0/100

Magnesium sulfate in erector spinae plane block is a Small molecule drug developed by Assiut University. It is currently in Phase 1 development.

At a glance

Generic nameMagnesium sulfate in erector spinae plane block
SponsorAssiut University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Magnesium sulfate in erector spinae plane block

What is Magnesium sulfate in erector spinae plane block?

Magnesium sulfate in erector spinae plane block is a Small molecule drug developed by Assiut University.

Who makes Magnesium sulfate in erector spinae plane block?

Magnesium sulfate in erector spinae plane block is developed by Assiut University (see full Assiut University pipeline at /company/assiut-university).

What development phase is Magnesium sulfate in erector spinae plane block in?

Magnesium sulfate in erector spinae plane block is in Phase 1.

Related